Volumetric Abdominal Aortic Aneurysm Analysis in Post EVAR Surveillance Settings.

Introduction: Early detection of abdominal aortic aneurysms (AAA) is a mainstay of diagnosis, with Endovascular aortic repair (EVAR) emerging as the primary mode of repair. Maximum diameter measurement remains central to risk assessment; however, recent studies suggest AAA volumetric analysis may be more sensitive to true size changes. We compare the utility of volume and diameter in AAA size assessment and further investigating related clinical factors.

Genome Sequences of three CT cluster Bacteriophages isolated in Durham, North Carolina on .

PotPie, HippoPololi and BillDoor are bacteriophages with siphoviral morphologies that were isolated from soil in North Carolina using . The three phages are all grouped in the CT cluster, with genomes of 48182 bp, 45423 bp, and 44875 bp, respectively, and are predicted to be lytic.

Understanding Utilization and Prevention Measures Associated With a Caries Risk Assessment in Oral Health Transformation.

Objectives: Dental decay is endemic in the United States, underscoring the need to measure the utilization of caries risk management tools to elucidate the effect of prevention interventions in reducing the dental decay rates of individuals. An academic institution partnered with a third-party institute to call attention to the utilization and prevention measures associated with caries risk assessment (CRA) used with children 0-18 years. This environmental scan examined claims across the United States to evaluate the proportion of dental examinations, CRAs, and caries prevention procedures within a calendar year.

Real-world experiences of adult individuals or caregivers of children who received teplizumab treatment in stage 2 type 1 diabetes.

Aims: This study surveyed individuals and caregivers of children who received teplizumab at stage 2 type 1 diabetes (T1D) to garner real-world experiences and their health outlook for the future following treatment with the first approved disease-modifying immune therapy for delaying the onset of Stage 3 T1D.

Materials And Methods: This was a cross-sectional, observational, online survey (conducted September-October 2024) of adults (≥18 years) and caregivers of children (8-17 years) who received teplizumab while participating in the US COMPASS patient support program. Questions pertained to demographics, health history, T1D screening, the decision to take teplizumab, treatment, post-treatment experience, outlook on prognosis and self-reported health status.